ClinicalTrials.gov
public full text
Public Domain
Highlanders With High Altitude Pulmonary Hypertension (HAPH), Pulmonary Arterial Pressure (PAP) Assessed at 3200m With and Without Supplemental Oxygen Therapy (SOT)
The investigators aim to study the effect of SOT in highlanders with high altitude pulmonary hypertension (HAPH) who permanently live \>2500m on pulmonary arterial pressure (PAP) assessed at 3200 m.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Incidence and Clinical Characteristics of Pulmonary Hypertension Secondary to ARDS in the Highland#909039
- Acclimatization of Healthy Subjects During a Stay at 3200 m#859000
- Adaptation of Lung Transplant Recipients at Extreme Altitude#1138302
- Endothelial Progenitor Cells and Pulmonary Idiopathic Arterial Hypertension#325203
- Endothelial Function in Patients With Pulmonary Arterial Hypertension#394643
Record · ID 1408957
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive